Filing Details

Accession Number:
0001209191-18-011628
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-20 20:07:09
Reporting Period:
2018-02-16
Accepted Time:
2018-02-20 20:07:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Healthcare Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1373493 B Jonathan Perlin One Park Plaza
Nashville TN 37203
Pres-Clinical Services & Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-16 38,480 $17.33 119,778 No 4 M Direct
Common Stock Disposition 2018-02-16 38,480 $102.05 81,298 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-16 980 $0.00 980 $17.33
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-02-16 37,500 $0.00 37,500 $17.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
36,520 2021-11-02 No 4 M Direct
0 2021-11-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 913 Indirect By 2011 GRAT, Reporting Person Trustee
Common Stock 3,846 Indirect By 2012 GRAT, Reporting Person Trustee
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.19, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  3. The option vested in three equal annual installments beginning on November 2, 2013.
  4. Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
  5. The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets.